Immune System News and Research

RSS

GNC introduces clinically tested immune defense product

GNC has announced the introduction of its latest immune health product, ViraBLOC. ViraBLOC is a clinically tested immune defense product based on patent-pending elderberry extract from HerbalScience Group and is now available nationwide through GNC.

7 Oct 2009

Researchers make breakthrough in finding a vaccine against horse disease strangle

A research group at the Department of Microbiology, Swedish University of Agricultural Sciences (SLU) in Uppsala, Sweden has - in collaboration with J-I Flock's research group at the Karolinska Institutet medical university in Stockholm, the pharmacological company Intervacc AB, Stockholm and the Animal Health Trust in the UK - after many years of research made a breakthrough in finding a vaccine against the horse disease strangle.

7 Oct 2009

Health educator stresses the importance of sinus cleansing

With fall allergy season underway and Americans concerned about keeping their family safe from H1N1 and other flu viruses, health educator and fitness trainer Isabella "Betti" Jones is urging Americans to take a proactive, natural approach to staying healthy - the important step of daily sinus cleansing.

6 Oct 2009

pDCs promote growth and survival of malignant myeloma cells

Multiple myeloma cancer cells thwart many of the drugs used against them by causing nearby cells to turn traitor - to switch from defending the body against disease to shielding the myeloma cells from harm - Dana-Farber Cancer Institute scientists report in the October issue of Cancer Cell.

6 Oct 2009

NovImmune wins the 2009 EUROPEAN BIOTECHNICA AWARD

The winner of the 2009 EUROPEAN BIOTECHNICA AWARD is NovImmune SA from Switzerland. This biopharmaceutical company duly receives the lion’s share of the €100,000 prize money, which is awarded each year by Deutsche Messe AG and its partners. The aim of the award is to celebrate the achievements of innovative European companies in the field of biotechnology and the life sciences.

6 Oct 2009

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

PDS Biotechnology Corporation today announced that the company has completed GLP toxicology studies of its lead HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the evaluation of toxicity, all demonstrated a very safe profile of the drug and PDS Biotech's platform Versamune((TM)) technology.

6 Oct 2009

Ground Zero Pharmaceuticals opens new office in Brisbane

A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.

6 Oct 2009

Lady Foot Locker's initiative for breast cancer awareness

In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).

6 Oct 2009

Promising alternative to use of live animals for drug testing

International Stem Cell Corporation, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO’s stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.

6 Oct 2009

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Mari Hashitate Dallas of St. Jude Children’s Research Hospital in Memphis, Tenn., the Millipore Guava® Flow Cytometry Award.

6 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Researchers identify novel circulation within human eye that provides new insight into glaucoma

Researchers at the University of Toronto, St. Michael's Hospital and Sunnybrook Health Sciences Centre have discovered a previously unidentified form of circulation within the human eye which may provide important new insights into glaucoma, a leading cause of blindness.

6 Oct 2009

New study to boost immune cells for pathogen resistance and vaccine efficacy in elderly

A new study from the Trudeau Institute in Saranac Lake, New York, demonstrates that immune system cells important for both pathogen resistance and vaccine efficacy live longer in older animals but because of this longevity acquire functional defects. The work may provide new targets for boosting immune system function in older individuals.

6 Oct 2009

Survival rates for multivisceral transplants increase with new treatment strategies

Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery.

6 Oct 2009

Key defence mechanism used by the immune system against Listeria identified

A team of University of British Columbia microbiologists has identified a key defence mechanism used by the immune system against Listeria with strong implications for the future development of vaccines.

6 Oct 2009

Inviragen, SingVax merge their complementary vaccine pipelines

Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.

6 Oct 2009

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.

5 Oct 2009

Autistic patients have underlying medical disorders that are amenable to treatment

The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.

5 Oct 2009

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

5 Oct 2009

Immune System News and Research

GNC introduces clinically tested immune defense product

Researchers make breakthrough in finding a vaccine against horse disease strangle

Health educator stresses the importance of sinus cleansing

pDCs promote growth and survival of malignant myeloma cells

NovImmune wins the 2009 EUROPEAN BIOTECHNICA AWARD

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

Ground Zero Pharmaceuticals opens new office in Brisbane

Lady Foot Locker's initiative for breast cancer awareness

Promising alternative to use of live animals for drug testing

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Vivaldi receives US patent for live attenuated influenza vaccines

Researchers identify novel circulation within human eye that provides new insight into glaucoma

New study to boost immune cells for pathogen resistance and vaccine efficacy in elderly

Survival rates for multivisceral transplants increase with new treatment strategies

Key defence mechanism used by the immune system against Listeria identified

Inviragen, SingVax merge their complementary vaccine pipelines

Depression leads to elevated inflammatory proteins in the human body: Study

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

Autistic patients have underlying medical disorders that are amenable to treatment

Research confirms that probiotic bacteria promotes health and boosts immune system

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News